Skip to main content
SpringerLink
Log in
Book cover

Myasthenia Gravis and Related Disorders pp 71–78Cite as

Epidemiology and Genetics of Myasthenia Gravis

  • Chapter
  • First Online:

  • 1873 Accesses

Part of the book series: Current Clinical Neurology ((CCNEU))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

REFERENCES

  1. Phillips LH, Torner J. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996;47:1233–1238.

    PubMed  Google Scholar 

  2. Phillips LH. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003;998:407–412.

    Article  PubMed  Google Scholar 

  3. Phillips LH, Torner JC, Anderson MS, Cox GM. The epidemiology of myasthenia gravis in central and western Virginia. Neurology, 1992;42:1888–1893.

    PubMed  Google Scholar 

  4. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991;48:733–739.

    Article  PubMed  CAS  Google Scholar 

  5. Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology. 2005;65:928–930.

    Article  PubMed  CAS  Google Scholar 

  6. Aragones JM, Bolibar I, Bonfill X et al. Myasthenia gravis: a higher than expected incidence in the elderly. Neurology. 2003;60:1024–1026.

    PubMed  CAS  Google Scholar 

  7. Matsuda M, Dohi-Iijima N, Nakamura A et al. Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med. 2005;44:572–577.

    Article  PubMed  Google Scholar 

  8. Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann N Y Acad Sci. 2003;998:424–431.

    Article  PubMed  Google Scholar 

  9. Donaldson DH, Ansher M, Horan S et al. The relationship of age to outcome in myasthenia gravis. Neurology. 1990;40:786–790.

    PubMed  CAS  Google Scholar 

  10. Vincent A, McConville J, Farrugia ME, Newsom-Davis J. Seronegative myasthenia gravis. Semin Neurol. 2004;24:125–133.

    Article  PubMed  Google Scholar 

  11. Lavrnic D, Losen M, Vujic A et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry. 2005;76:1099–1102.

    Article  PubMed  CAS  Google Scholar 

  12. Hoch W, McConville J, Helms S et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365–368.

    Google Scholar 

  13. Yeh JH, Chen WH, Chiu HC, Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology. 2004;62:2131–2132.

    PubMed  Google Scholar 

  14. Lee JY, Sung JJ, Cho JY et al. MuSK antibody-positive, seronegative myasthenia gravis in Korea. J Clin Neurosci. 2006;13:353–5. Epub 2006 Mar 20.

    Article  PubMed  Google Scholar 

  15. Sanders DB, El-Salem K, Massey JM et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology. 2003;60:1978–1980.

    PubMed  CAS  Google Scholar 

  16. Namba T, Brunner NG, Brown SB et al. Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol. 1971;25:49–60.

    Article  PubMed  CAS  Google Scholar 

  17. Namba T, Shapiro MS, Brunner NG, Grob D. Myasthenia gravis occurring in twins. J Neurol Neurosurg Psychiatry. 1971;34:531–534.

    Article  PubMed  CAS  Google Scholar 

  18. Bergoffen J, Zmijewski CM, Fischbeck KH. Familial autoimmune myasthenia gravis. Neurology. 1994;44:551–554.

    PubMed  CAS  Google Scholar 

  19. Kerzin-Storrar L, Metcalfe RA, Dyer PA et al. Genetic factors in myasthenia gravis: a family study. Neurology. 1988;38:38–42.

    PubMed  CAS  Google Scholar 

  20. Evoli A, Batocchi AP, Zelano G et al. Familial autoimmune myasthenia gravis: report of four families. J Neurol Neurosurg Psychiatry. 1995;58:729–731.

    Article  PubMed  CAS  Google Scholar 

  21. Giraud M, Beaurain G, Yamamoto AM et al. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology. 2001;57:1555–1560.

    PubMed  CAS  Google Scholar 

  22. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257–274.

    Article  PubMed  CAS  Google Scholar 

  23. Vandiedonck C, Giraud M, Garchon HJ. Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex. J Autoimmun. 2005;25 Suppl:6–11. Epub 2005 Nov 2.

    Article  PubMed  CAS  Google Scholar 

  24. Garchon HJ, Djabiri F, Viard JP et al. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci U S A. 1994;91:4668–4672.

    Article  PubMed  CAS  Google Scholar 

  25. Djabiri F, Caillat-Zucman S, Gajdos P et al. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun. 1997;10:407–413.

    Article  PubMed  CAS  Google Scholar 

  26. Garchon HJ. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man. J Autoimmun. 2003;21:105–110.

    Article  PubMed  CAS  Google Scholar 

  27. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity? Genes Immun. 2000;1:170–84.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Virginia, Charlottesville, Virginia

    Jeremiah W. Lanford (MD) & Lawrence H. Phillips (II MD)

Authors
  1. Jeremiah W. Lanford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence H. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lanford, J.W., Phillips, L.H. (2009). Epidemiology and Genetics of Myasthenia Gravis. In: Myasthenia Gravis and Related Disorders. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-156-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-156-7_4

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-852-2

  • Online ISBN: 978-1-59745-156-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation